In vitro synergistic activity of the sulbactam/avibactam combination against extensively drug-resistant Acinetobacter baumannii

In vitro synergistic activity of the sulbactam/avibactam combination against extensively drug-resistant Acinetobacter baumannii

Introduction. The therapeutic options to treat Acinetobacter baumannii infections are very limited. Aim. Our aim was to evaluate the activity of sulbactam combined directly with avibactam or the ampicillin-sulbactam/ceftazidime-avibactam combination against extensively drug-resistant A. baumannii is...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medical microbiology 2020-07, Vol.69 (7), p.928-931
Hauptverfasser: Rodriguez, Carlos Hernán, Brune, Adriana, Nastro, Marcela, Vay, Carlos, Famiglietti, Angela
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 931
container_issue 7
container_start_page 928
container_title Journal of medical microbiology
container_volume 69
creator Rodriguez, Carlos Hernán
Brune, Adriana
Nastro, Marcela
Vay, Carlos
Famiglietti, Angela
description Introduction. The therapeutic options to treat Acinetobacter baumannii infections are very limited. Aim. Our aim was to evaluate the activity of sulbactam combined directly with avibactam or the ampicillin-sulbactam/ceftazidime-avibactam combination against extensively drug-resistant A. baumannii isolates. Methodology. Extensively drug-resistant A. baumannii isolates ( n =127) collected at several South American hospitals were studied. Synergy with the sulbactam/avibactam combination was assessed in all isolates using the agar dilution method. Avibactam was used at a fixed concentration of 4 mg l −1 . A disc diffusion synergy test was also performed. Synergy by a time-kill experiment was performed in a selected isolate. Results. Synergy with sulbactam/avibactam was demonstrated in 124 isolates and it showed MIC values ≤4 mg l −1 . This synergy was not detected in the three New Delhi metallo-β-lactamase-harbouring isolates. Similar results were observed with the disc diffusion synergy test of ampicillin-sulbactam/ceftazidime-avibactam. In the time-kill experiments, sulbactam/avibactam showed a rapid synergistic and bactericidal activity in ampicillin-sulbactam-resistant isolates. Conclusions. This study demonstrated that the sulbactam/avibactam combination displayed synergistic activity against A. baumannii isolates. This synergy was observed when both inhibitors were also used as part of the commercially available combinations: ampicillin-sulbactam and ceftazidime-avibactam.
doi_str_mv 10.1099/jmm.0.001211
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2417396055</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2417396055</sourcerecordid><originalsourceid>FETCH-LOGICAL-c306t-c97dc490dc81a1eb8f58ee6bb8bb94c8758baf57b6cd8b9f5c4143be2307f7f23</originalsourceid><addsrcrecordid>eNotkDtPwzAUhS0EEqWw8QM8MpDWju08xqriJVVigdmynZviKrGL7VRk4q-TKkz36ug7Z_gQuqdkRUldrw99vyIrQmhO6QVaUF6yTBScX6IFIXme5QUV1-gmxsPElIzVC_T75vDJpuBxHB2EvY3JGqxMslM6Yt_i9AU4Dp2eMtWv1cnOHza-19apZL3Daq-siwnDTwIX7Qm6ETdh2GcB4rSoXMIbYx0kfy5DwFoNvXLO2lt01aouwt3_XaLP56eP7Wu2e3952252mWGkSJmpy8bwmjSmooqCrlpRARRaV1rX3FSlqLRqRakL01S6boXhlDMNOSNlW7Y5W6KHefcY_PcAMcneRgNdpxz4IcqcT0LqgggxoY8zaoKPMUArj8H2KoySEnn2LCfPksjZM_sDQUN1jA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2417396055</pqid></control><display><type>article</type><title>In vitro synergistic activity of the sulbactam/avibactam combination against extensively drug-resistant Acinetobacter baumannii</title><source>Microbiology Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Rodriguez, Carlos Hernán ; Brune, Adriana ; Nastro, Marcela ; Vay, Carlos ; Famiglietti, Angela</creator><creatorcontrib>Rodriguez, Carlos Hernán ; Brune, Adriana ; Nastro, Marcela ; Vay, Carlos ; Famiglietti, Angela</creatorcontrib><description>Introduction. The therapeutic options to treat Acinetobacter baumannii infections are very limited. Aim. Our aim was to evaluate the activity of sulbactam combined directly with avibactam or the ampicillin-sulbactam/ceftazidime-avibactam combination against extensively drug-resistant A. baumannii isolates. Methodology. Extensively drug-resistant A. baumannii isolates ( n =127) collected at several South American hospitals were studied. Synergy with the sulbactam/avibactam combination was assessed in all isolates using the agar dilution method. Avibactam was used at a fixed concentration of 4 mg l −1 . A disc diffusion synergy test was also performed. Synergy by a time-kill experiment was performed in a selected isolate. Results. Synergy with sulbactam/avibactam was demonstrated in 124 isolates and it showed MIC values ≤4 mg l −1 . This synergy was not detected in the three New Delhi metallo-β-lactamase-harbouring isolates. Similar results were observed with the disc diffusion synergy test of ampicillin-sulbactam/ceftazidime-avibactam. In the time-kill experiments, sulbactam/avibactam showed a rapid synergistic and bactericidal activity in ampicillin-sulbactam-resistant isolates. Conclusions. This study demonstrated that the sulbactam/avibactam combination displayed synergistic activity against A. baumannii isolates. This synergy was observed when both inhibitors were also used as part of the commercially available combinations: ampicillin-sulbactam and ceftazidime-avibactam.</description><identifier>ISSN: 0022-2615</identifier><identifier>EISSN: 1473-5644</identifier><identifier>DOI: 10.1099/jmm.0.001211</identifier><language>eng</language><ispartof>Journal of medical microbiology, 2020-07, Vol.69 (7), p.928-931</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c306t-c97dc490dc81a1eb8f58ee6bb8bb94c8758baf57b6cd8b9f5c4143be2307f7f23</citedby><cites>FETCH-LOGICAL-c306t-c97dc490dc81a1eb8f58ee6bb8bb94c8758baf57b6cd8b9f5c4143be2307f7f23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3746,27924,27925</link.rule.ids></links><search><creatorcontrib>Rodriguez, Carlos Hernán</creatorcontrib><creatorcontrib>Brune, Adriana</creatorcontrib><creatorcontrib>Nastro, Marcela</creatorcontrib><creatorcontrib>Vay, Carlos</creatorcontrib><creatorcontrib>Famiglietti, Angela</creatorcontrib><title>In vitro synergistic activity of the sulbactam/avibactam combination against extensively drug-resistant Acinetobacter baumannii</title><title>Journal of medical microbiology</title><description>Introduction. The therapeutic options to treat Acinetobacter baumannii infections are very limited. Aim. Our aim was to evaluate the activity of sulbactam combined directly with avibactam or the ampicillin-sulbactam/ceftazidime-avibactam combination against extensively drug-resistant A. baumannii isolates. Methodology. Extensively drug-resistant A. baumannii isolates ( n =127) collected at several South American hospitals were studied. Synergy with the sulbactam/avibactam combination was assessed in all isolates using the agar dilution method. Avibactam was used at a fixed concentration of 4 mg l −1 . A disc diffusion synergy test was also performed. Synergy by a time-kill experiment was performed in a selected isolate. Results. Synergy with sulbactam/avibactam was demonstrated in 124 isolates and it showed MIC values ≤4 mg l −1 . This synergy was not detected in the three New Delhi metallo-β-lactamase-harbouring isolates. Similar results were observed with the disc diffusion synergy test of ampicillin-sulbactam/ceftazidime-avibactam. In the time-kill experiments, sulbactam/avibactam showed a rapid synergistic and bactericidal activity in ampicillin-sulbactam-resistant isolates. Conclusions. This study demonstrated that the sulbactam/avibactam combination displayed synergistic activity against A. baumannii isolates. This synergy was observed when both inhibitors were also used as part of the commercially available combinations: ampicillin-sulbactam and ceftazidime-avibactam.</description><issn>0022-2615</issn><issn>1473-5644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNotkDtPwzAUhS0EEqWw8QM8MpDWju08xqriJVVigdmynZviKrGL7VRk4q-TKkz36ug7Z_gQuqdkRUldrw99vyIrQmhO6QVaUF6yTBScX6IFIXme5QUV1-gmxsPElIzVC_T75vDJpuBxHB2EvY3JGqxMslM6Yt_i9AU4Dp2eMtWv1cnOHza-19apZL3Daq-siwnDTwIX7Qm6ETdh2GcB4rSoXMIbYx0kfy5DwFoNvXLO2lt01aouwt3_XaLP56eP7Wu2e3952252mWGkSJmpy8bwmjSmooqCrlpRARRaV1rX3FSlqLRqRakL01S6boXhlDMNOSNlW7Y5W6KHefcY_PcAMcneRgNdpxz4IcqcT0LqgggxoY8zaoKPMUArj8H2KoySEnn2LCfPksjZM_sDQUN1jA</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Rodriguez, Carlos Hernán</creator><creator>Brune, Adriana</creator><creator>Nastro, Marcela</creator><creator>Vay, Carlos</creator><creator>Famiglietti, Angela</creator><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20200701</creationdate><title>In vitro synergistic activity of the sulbactam/avibactam combination against extensively drug-resistant Acinetobacter baumannii</title><author>Rodriguez, Carlos Hernán ; Brune, Adriana ; Nastro, Marcela ; Vay, Carlos ; Famiglietti, Angela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c306t-c97dc490dc81a1eb8f58ee6bb8bb94c8758baf57b6cd8b9f5c4143be2307f7f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rodriguez, Carlos Hernán</creatorcontrib><creatorcontrib>Brune, Adriana</creatorcontrib><creatorcontrib>Nastro, Marcela</creatorcontrib><creatorcontrib>Vay, Carlos</creatorcontrib><creatorcontrib>Famiglietti, Angela</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medical microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rodriguez, Carlos Hernán</au><au>Brune, Adriana</au><au>Nastro, Marcela</au><au>Vay, Carlos</au><au>Famiglietti, Angela</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro synergistic activity of the sulbactam/avibactam combination against extensively drug-resistant Acinetobacter baumannii</atitle><jtitle>Journal of medical microbiology</jtitle><date>2020-07-01</date><risdate>2020</risdate><volume>69</volume><issue>7</issue><spage>928</spage><epage>931</epage><pages>928-931</pages><issn>0022-2615</issn><eissn>1473-5644</eissn><abstract>Introduction. The therapeutic options to treat Acinetobacter baumannii infections are very limited. Aim. Our aim was to evaluate the activity of sulbactam combined directly with avibactam or the ampicillin-sulbactam/ceftazidime-avibactam combination against extensively drug-resistant A. baumannii isolates. Methodology. Extensively drug-resistant A. baumannii isolates ( n =127) collected at several South American hospitals were studied. Synergy with the sulbactam/avibactam combination was assessed in all isolates using the agar dilution method. Avibactam was used at a fixed concentration of 4 mg l −1 . A disc diffusion synergy test was also performed. Synergy by a time-kill experiment was performed in a selected isolate. Results. Synergy with sulbactam/avibactam was demonstrated in 124 isolates and it showed MIC values ≤4 mg l −1 . This synergy was not detected in the three New Delhi metallo-β-lactamase-harbouring isolates. Similar results were observed with the disc diffusion synergy test of ampicillin-sulbactam/ceftazidime-avibactam. In the time-kill experiments, sulbactam/avibactam showed a rapid synergistic and bactericidal activity in ampicillin-sulbactam-resistant isolates. Conclusions. This study demonstrated that the sulbactam/avibactam combination displayed synergistic activity against A. baumannii isolates. This synergy was observed when both inhibitors were also used as part of the commercially available combinations: ampicillin-sulbactam and ceftazidime-avibactam.</abstract><doi>10.1099/jmm.0.001211</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-2615
ispartof Journal of medical microbiology, 2020-07, Vol.69 (7), p.928-931
issn 0022-2615
1473-5644
language eng
recordid cdi_proquest_miscellaneous_2417396055
source Microbiology Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title In vitro synergistic activity of the sulbactam/avibactam combination against extensively drug-resistant Acinetobacter baumannii
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T15%3A47%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20synergistic%20activity%20of%20the%20sulbactam/avibactam%20combination%20against%20extensively%20drug-resistant%20Acinetobacter%20baumannii&rft.jtitle=Journal%20of%20medical%20microbiology&rft.au=Rodriguez,%20Carlos%20Hern%C3%A1n&rft.date=2020-07-01&rft.volume=69&rft.issue=7&rft.spage=928&rft.epage=931&rft.pages=928-931&rft.issn=0022-2615&rft.eissn=1473-5644&rft_id=info:doi/10.1099/jmm.0.001211&rft_dat=%3Cproquest_cross%3E2417396055%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2417396055&rft_id=info:pmid/&rfr_iscdi=true